- Home
- MRNA vs BWXT Comparison
MRNA vs BWXT Comparison
Compare MRNA & BWXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- BWXT
- Stock Information
- Founded
- MRNA 2010
- BWXT 1867
- Country
- MRNA United States
- BWXT United States
- Employees
- MRNA N/A
- BWXT N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- BWXT
- Sector
- MRNA Health Care
- BWXT
- Exchange
- MRNA Nasdaq
- BWXT Nasdaq
- Market Cap
- MRNA 10.6B
- BWXT 8.6B
- IPO Year
- MRNA 2018
- BWXT N/A
- Fundamental
- Price
- MRNA $26.56
- BWXT $125.90
- Analyst Decision
- MRNA Hold
- BWXT Strong Buy
- Analyst Count
- MRNA 19
- BWXT 11
- Target Price
- MRNA $48.13
- BWXT $131.36
- AVG Volume (30 Days)
- MRNA 14.2M
- BWXT 1.2M
- Earning Date
- MRNA 05-01-2025
- BWXT 05-05-2025
- Dividend Yield
- MRNA N/A
- BWXT 0.80%
- EPS Growth
- MRNA N/A
- BWXT 13.77
- EPS
- MRNA N/A
- BWXT 3.14
- Revenue
- MRNA $3,177,000,000.00
- BWXT $2,781,946,000.00
- Revenue This Year
- MRNA N/A
- BWXT $15.14
- Revenue Next Year
- MRNA $8.98
- BWXT $9.77
- P/E Ratio
- MRNA N/A
- BWXT $40.00
- Revenue Growth
- MRNA N/A
- BWXT 9.88
- 52 Week Low
- MRNA $23.15
- BWXT $84.21
- 52 Week High
- MRNA $158.82
- BWXT $136.31
- Technical
- Relative Strength Index (RSI)
- MRNA 50.60
- BWXT 74.95
- Support Level
- MRNA $25.22
- BWXT $106.22
- Resistance Level
- MRNA $27.15
- BWXT $127.64
- Average True Range (ATR)
- MRNA 1.61
- BWXT 3.45
- MACD
- MRNA 0.26
- BWXT 1.73
- Stochastic Oscillator
- MRNA 47.66
- BWXT 91.01
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About BWXT BWX Technologies Inc.
BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.